What does Apotheek Kempinaire do?

Apotheek Kempinaire is a pharmacy in Avelgem. Private Limited, started on 23 December 1992, 1 establishment.

What is the address of Apotheek Kempinaire?

The registered office of Apotheek Kempinaire is located at Doorniksesteenweg 22, 8580 Avelgem.

Is Apotheek Kempinaire still active?

Yes. According to the CBE (30 October 2026) Apotheek Kempinaire is active, legal situation “Normale toestand”, started on 23 December 1992.

Is Apotheek Kempinaire registered on Peppol?

Yes, Apotheek Kempinaire is registered on the Peppol network with ID 0208:0449034378.

What is the enterprise number of Apotheek Kempinaire?

The enterprise number of Apotheek Kempinaire is BE0449034378.

When was Apotheek Kempinaire founded?

Apotheek Kempinaire was founded on 23 December 1992.

Who are the directors of Apotheek Kempinaire?

According to the 2025 annual accounts, the directors of Apotheek Kempinaire are: Nadine Kempinaire.

Is Apotheek Kempinaire a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 December 1992; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek Kempinaire make in 2025?

Apotheek Kempinaire posted a profit after taxes of € 291 in financial year 2025.

What is the revenue of Apotheek Kempinaire?

As a small company, Apotheek Kempinaire is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 76,074.

Apotheek Kempinaire (Private Limited) - Avelgem

Dossier Apotheek Kempinaire, printed on 30 October 2026 from databakkes.be/en/0449034378/apotheek-kempinaire. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek Kempinaire from Avelgem, company number BE0449034378, closed financial year 2025 with a result of € 291 after tax. For that financial year Apotheek Kempinaire recorded a gross margin of € 76,074 and equity of € 208,098. Compared with financial year 2024, the result moved from € 5,786 to € 291. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 18, 2026.

What it is worth Growing

€ 208,098

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 291

▼ 95% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 197,013

▲ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 189,506.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 68,204

▲ 31% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 45,389

▲ 17% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 13,516

▲ 14% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 90,025 Gross margin 2022: € 90,025 First fiscal year in the series	€ 83,767 Gross margin 2023: € 83,767 ▼ 7% vs 2022 (€ 90,025) Unfavourable step	€ 66,552 Gross margin 2024: € 66,552 ▼ 21% vs 2023 (€ 83,767) Unfavourable step	€ 76,074 Gross margin 2025: € 76,074 ▲ 14% vs 2024 (€ 66,552) Favourable step	▲ 14%
Profit after taxes	€ 29,706 Profit after taxes 2022: € 29,706 First fiscal year in the series	€ 19,676 Profit after taxes 2023: € 19,676 ▼ 34% vs 2022 (€ 29,706) Unfavourable step	€ 5,786 Profit after taxes 2024: € 5,786 ▼ 71% vs 2023 (€ 19,676) Unfavourable step	€ 291 Profit after taxes 2025: € 291 ▼ 95% vs 2024 (€ 5,786) Unfavourable step	▼ 95%
Equity	€ 182,345 Equity 2022: € 182,345 First fiscal year in the series	€ 202,021 Equity 2023: € 202,021 ▲ 11% vs 2022 (€ 182,345) Favourable step	€ 207,807 Equity 2024: € 207,807 ▲ 3% vs 2023 (€ 202,021) Favourable step	€ 208,098 Equity 2025: € 208,098 Unchanged (€ 207,807) Favourable step
Total debts	€ 116,227 Total debts 2022: € 116,227 First fiscal year in the series	€ 105,582 Total debts 2023: € 105,582 ▼ 9% vs 2022 (€ 116,227) Favourable step	€ 112,350 Total debts 2024: € 112,350 ▲ 6% vs 2023 (€ 105,582) Unfavourable step	€ 125,699 Total debts 2025: € 125,699 ▲ 12% vs 2024 (€ 112,350) Unfavourable step	▲ 12%
Cash	€ 172,671 Cash 2022: € 172,671 First fiscal year in the series	€ 182,428 Cash 2023: € 182,428 ▲ 6% vs 2022 (€ 172,671) Favourable step	€ 188,130 Cash 2024: € 188,130 ▲ 3% vs 2023 (€ 182,428) Favourable step	€ 197,013 Cash 2025: € 197,013 ▲ 5% vs 2024 (€ 188,130) Favourable step	▲ 5%
Retained profit	€ 163,753 Retained profit 2022: € 163,753 First fiscal year in the series	€ 183,429 Retained profit 2023: € 183,429 ▲ 12% vs 2022 (€ 163,753) Favourable step	€ 189,215 Retained profit 2024: € 189,215 ▲ 3% vs 2023 (€ 183,429) Favourable step	€ 189,506 Retained profit 2025: € 189,506 Unchanged (€ 189,215) Favourable step
Balance sheet total	€ 298,572 Balance sheet total 2022: € 298,572 First fiscal year in the series	€ 307,603 Balance sheet total 2023: € 307,603 ▲ 3% vs 2022 (€ 298,572) Unchanged	€ 320,157 Balance sheet total 2024: € 320,157 ▲ 4% vs 2023 (€ 307,603) Unchanged	€ 333,797 Balance sheet total 2025: € 333,797 ▲ 4% vs 2024 (€ 320,157) Unchanged	▲ 4%

Key figures of Apotheek Kempinaire, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to Apotheek Kempinaire?

What happened at Apotheek Kempinaire in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Feb 18, 2026 New annual accounts for financial year 2025: profit of € 291 (▼ 95% vs 2024). filed late Source: NBB ↗
2021 Nadine Kempinaire became a director. NBB
Dec 2, 2012 New establishment in Avelgem. KBO
Dec 23, 1992 Start of the company according to the CBE. KBO

In short

From € 29,706 profit in 2022 to € 291 profit in 2025.

Paid € 22,653 in corporate taxes since 2022.

Best year ever: 2022, with € 29,706 profit.

Original PDFs at the National Bank ↗

Management

Nadine Kempinaire

Apotheek Kempinaire

Behind Apotheek Kempinaire is Nadine Kempinaire.

Directors

According to the 2025 annual accounts

Nadine Kempinaire

Director

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Doorniksesteenweg 22

8580 Avelgem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

PHARMFLY

€ 32,018 gross margin · 2025

E.R.C.

€ 60,871 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0449.034.378
VAT number: BE 0449.034.378
Registered office: Doorniksesteenweg 22, 8580 Avelgem
Names & denominations: Apotheek Kempinaire
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 December 1992
Peppol: Active · Active since 14 Nov 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗